Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma

PURPOSE: Although the prognosis is generally good in patients with intermediate-risk neuroblastoma, no consensus has been reached on the ideal treatment regimen. This study analyzed treatment outcomes and toxicities in patients younger than 18 months with stage 4 MYCN nonamplified neuroblastoma. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chiwoo, Choi, Young Bae, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854843/
https://www.ncbi.nlm.nih.gov/pubmed/29563945
http://dx.doi.org/10.3345/kjp.2018.61.2.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854843/
https://www.ncbi.nlm.nih.gov/pubmed/29563945
http://dx.doi.org/10.3345/kjp.2018.61.2.53

Ejemplares similares